Download PDF
1 / Pages

Other users also viewed these articles

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation Ismael Francisco Aomar-Millán; Juan Salvatierra; Úrsula Torres-Parejo; María Nuñez-Nuñez; José Hernández-Quero; Francisco Anguita-Santos;
Med Clin. 2021;156:602-5
Influence of smoking history on the evolution of hospitalized in COVID-19 positive patients: Results from the SEMI-COVID-19 registry María Sierra Navas Alcántara; Lorena Montero Rivas; María Esther Guisado Espartero; Manuel Rubio-Rivas; Blanca Ayuso García; Francisco Moreno Martinez; Cristina Ausín García; María Luisa Taboada Martínez; Francisco Arnalich Fernández; Raúl Martínez Murgui; Sonia Molinos Castro; Maria Esther Ramos Muñoz; Mar Fernández-Garcés; Mari Cruz Carreño Hernandez; Gema María García García; Nuria Vázquez Piqueras; Jesica Abadía-Otero; Lourdes Lajara Villar; Cristina Salazar Monteiro; María de los Reyes Pascual Pérez; Santiago Perez-Martin; Javier Collado-Aliaga; Juan-Miguel Antón-Santos; Carlos Lumbreras-Bermejo;
Med Clin. 2022;159:214-23
Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab Adrián Sánchez-Montalvá; Júlia Sellarés-Nadal; Juan Espinosa-Pereiro; Nuria Fernández-Hidalgo; Santiago Pérez-Hoyos; Fernando Salvador; Xavier Durà; Marta Miarons; Andrés Antón; Simeón Eremiev-Eremiev; Abiu Sempere-González; Arnau Monforte-Pallarés; Pau Bosch-Nicolau; Salvador Augustin; Júlia Sampol; Alfredo Guillén-del-Castillo; Benito Almirante;
Med Clin. 2022;158:509-18